Cary Street Partners’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Buy
64,439
+2,448
+4% +$171K 0.09% 231
2026
Q1
$4.68M Sell
61,991
-1,560
-2% -$111K 0.12% 188
2025
Q4
$3.92M Buy
63,551
+245
+0.4% +$14.4K 0.1% 212
2025
Q3
$3.72M Sell
63,306
-13
-0% -$758 0.1% 220
2025
Q2
$3.69M Buy
63,319
+5,385
+9% +$304K 0.1% 201
2025
Q1
$2.88M Buy
+57,934
New +$2.96M 0.09% 227

Other funds holding NTR

Cary Street Partners's NTR Position: Q2 2026 in Review

Cary Street Partners increased its Nutrien (NTR) stake by 3.9% in Q2 2026, buying an estimated $171K and bringing the position to 64,439 shares worth $4.06M. The position accounts for 0.09% of the portfolio, ranked #231.

Cary Street Partners first reported a position in NTR in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.68M in Q1 2026. 154 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Cary Street Partners held 64,439 shares of Nutrien worth $4.06M as of Q2 2026.
  • Cary Street Partners bought 2,448 Nutrien shares in Q2 2026, an estimated $171K.
  • Nutrien made up 0.09% of Cary Street Partners's portfolio in Q2 2026, its #231 holding.
  • Cary Street Partners first reported a position in Nutrien in Q1 2025 and has held it in 6 quarters since.
  • Cary Street Partners's Nutrien position peaked at $4.68M in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.